Emerging piezocatalysts have demonstrated their remarkable application potential in
diverse medical fields. In addition to their ultrahigh catalytic activities, their inherent and …

Dendrimers are a family of polymers with highly branched structure, well‐defined
composition, and extensive functional groups, which have attracted great attention in …

Nanoparticles for the detection and treatment of cancer have suffered from limited clinical
translation. A key problem has been the lack of understanding of the mechanisms of …

The use of biodegradable polymeric nanoparticles (NPs) for controlled drug delivery has
shown significant therapeutic potential. Concurrently, targeted delivery technologies are …

Nanomedicines, emerging as an innovative category of cancer therapeutics, have garnered
increasing attention from both researchers and the broader public. However, despite this …

The clinical prospects of cancer nanomedicines depend on effective patient stratification.
Here we report the identification of predictive biomarkers of the accumulation of …

The innovative development of nanomedicine has promised effective treatment options
compared to the standard therapeutics for cancer therapy. However, the efficiency of EPR …

Irinotecan (IRT), a classic clinical chemotherapeutic agent for treating colorectal cancer, has
been found to induce immunogenic cell death (ICD) while exerting cytotoxicity in tumor cells …

The main concept of radiosensitization is making the tumor tissue more responsive to
ionizing radiation, which leads to an increase in the potency of radiation therapy and allows …

Nanomedicine in oncology has not had the success in clinical impact that was anticipated in
the early stages of the field's development. Ideally, nanomedicines selectively accumulate in …